Bellevue Group »

Avidity Biosciences Ord shares owned by Bellevue Group

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Bellevue Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $94M 2.2M 43.57

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Alnylam Pharmaceuticals (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
Scholar Rock Hldg Corp (SRRK)
Akero Therapeutics (AKRO)
Immunocore Hldgs Ads (IMCR)

View all positions for Bellevue Group

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
Rtw Investments
Wellington Management Company
BlackRock
RA Capital Management
venBio Select Advisor
State Street Corporation
Geode Capital Management
Polar Capital Holdings
Bellevue Group
Casdin Capital
Goldman Sachs Group
OrbiMed Advisors

View all funds holding Avidity Biosciences Ord